Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Mebeverine Market Growth 2022-2028

  • LP 4760187
  • 106 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Mebeverine will have significant change from previous year. According to our (LP Information) latest study, the global Mebeverine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Mebeverine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Mebeverine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mebeverine market, reaching US$ million by the year 2028. As for the Europe Mebeverine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Mebeverine players cover Abbott, Mylan, Greville Investing Limited, and Expanscience, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Mebeverine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Capsule

Tablet

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Drug Store

On-line

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Abbott

Mylan

Greville Investing Limited

Expanscience

Berlin Pharmaceutical

Eipico Pharmaceutical

Sopharma

USV Private Limited

Puren Pharma

Pharco

Swiss Pharm

Dr. Reddy's

Aurovitas Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Mebeverine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Mebeverine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Mebeverine by Country/Region, 2017, 2022 & 2028

2.2 Mebeverine Segment by Type

2.2.1 Capsule

2.2.2 Tablet

2.3 Mebeverine Sales by Type

2.3.1 Global Mebeverine Sales Market Share by Type (2017-2022)

2.3.2 Global Mebeverine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Mebeverine Sale Price by Type (2017-2022)

2.4 Mebeverine Segment by Application

2.4.1 Hospital

2.4.2 Drug Store

2.4.3 On-line

2.5 Mebeverine Sales by Application

2.5.1 Global Mebeverine Sale Market Share by Application (2017-2022)

2.5.2 Global Mebeverine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Mebeverine Sale Price by Application (2017-2022)

3 Global Mebeverine by Company

3.1 Global Mebeverine Breakdown Data by Company

3.1.1 Global Mebeverine Annual Sales by Company (2020-2022)

3.1.2 Global Mebeverine Sales Market Share by Company (2020-2022)

3.2 Global Mebeverine Annual Revenue by Company (2020-2022)

3.2.1 Global Mebeverine Revenue by Company (2020-2022)

3.2.2 Global Mebeverine Revenue Market Share by Company (2020-2022)

3.3 Global Mebeverine Sale Price by Company

3.4 Key Manufacturers Mebeverine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Mebeverine Product Location Distribution

3.4.2 Players Mebeverine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Mebeverine by Geographic Region

4.1 World Historic Mebeverine Market Size by Geographic Region (2017-2022)

4.1.1 Global Mebeverine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Mebeverine Annual Revenue by Geographic Region

4.2 World Historic Mebeverine Market Size by Country/Region (2017-2022)

4.2.1 Global Mebeverine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Mebeverine Annual Revenue by Country/Region

4.3 Americas Mebeverine Sales Growth

4.4 APAC Mebeverine Sales Growth

4.5 Europe Mebeverine Sales Growth

4.6 Middle East & Africa Mebeverine Sales Growth

5 Americas

5.1 Americas Mebeverine Sales by Country

5.1.1 Americas Mebeverine Sales by Country (2017-2022)

5.1.2 Americas Mebeverine Revenue by Country (2017-2022)

5.2 Americas Mebeverine Sales by Type

5.3 Americas Mebeverine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Mebeverine Sales by Region

6.1.1 APAC Mebeverine Sales by Region (2017-2022)

6.1.2 APAC Mebeverine Revenue by Region (2017-2022)

6.2 APAC Mebeverine Sales by Type

6.3 APAC Mebeverine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Mebeverine by Country

7.1.1 Europe Mebeverine Sales by Country (2017-2022)

7.1.2 Europe Mebeverine Revenue by Country (2017-2022)

7.2 Europe Mebeverine Sales by Type

7.3 Europe Mebeverine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Mebeverine by Country

8.1.1 Middle East & Africa Mebeverine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Mebeverine Revenue by Country (2017-2022)

8.2 Middle East & Africa Mebeverine Sales by Type

8.3 Middle East & Africa Mebeverine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Mebeverine

10.3 Manufacturing Process Analysis of Mebeverine

10.4 Industry Chain Structure of Mebeverine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Mebeverine Distributors

11.3 Mebeverine Customer

12 World Forecast Review for Mebeverine by Geographic Region

12.1 Global Mebeverine Market Size Forecast by Region

12.1.1 Global Mebeverine Forecast by Region (2023-2028)

12.1.2 Global Mebeverine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Mebeverine Forecast by Type

12.7 Global Mebeverine Forecast by Application

13 Key Players Analysis

13.1 Abbott

13.1.1 Abbott Company Information

13.1.2 Abbott Mebeverine Product Offered

13.1.3 Abbott Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abbott Main Business Overview

13.1.5 Abbott Latest Developments

13.2 Mylan

13.2.1 Mylan Company Information

13.2.2 Mylan Mebeverine Product Offered

13.2.3 Mylan Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Mylan Main Business Overview

13.2.5 Mylan Latest Developments

13.3 Greville Investing Limited

13.3.1 Greville Investing Limited Company Information

13.3.2 Greville Investing Limited Mebeverine Product Offered

13.3.3 Greville Investing Limited Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Greville Investing Limited Main Business Overview

13.3.5 Greville Investing Limited Latest Developments

13.4 Expanscience

13.4.1 Expanscience Company Information

13.4.2 Expanscience Mebeverine Product Offered

13.4.3 Expanscience Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Expanscience Main Business Overview

13.4.5 Expanscience Latest Developments

13.5 Berlin Pharmaceutical

13.5.1 Berlin Pharmaceutical Company Information

13.5.2 Berlin Pharmaceutical Mebeverine Product Offered

13.5.3 Berlin Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Berlin Pharmaceutical Main Business Overview

13.5.5 Berlin Pharmaceutical Latest Developments

13.6 Eipico Pharmaceutical

13.6.1 Eipico Pharmaceutical Company Information

13.6.2 Eipico Pharmaceutical Mebeverine Product Offered

13.6.3 Eipico Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eipico Pharmaceutical Main Business Overview

13.6.5 Eipico Pharmaceutical Latest Developments

13.7 Sopharma

13.7.1 Sopharma Company Information

13.7.2 Sopharma Mebeverine Product Offered

13.7.3 Sopharma Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sopharma Main Business Overview

13.7.5 Sopharma Latest Developments

13.8 USV Private Limited

13.8.1 USV Private Limited Company Information

13.8.2 USV Private Limited Mebeverine Product Offered

13.8.3 USV Private Limited Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 USV Private Limited Main Business Overview

13.8.5 USV Private Limited Latest Developments

13.9 Puren Pharma

13.9.1 Puren Pharma Company Information

13.9.2 Puren Pharma Mebeverine Product Offered

13.9.3 Puren Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Puren Pharma Main Business Overview

13.9.5 Puren Pharma Latest Developments

13.10 Pharco

13.10.1 Pharco Company Information

13.10.2 Pharco Mebeverine Product Offered

13.10.3 Pharco Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Pharco Main Business Overview

13.10.5 Pharco Latest Developments

13.11 Swiss Pharm

13.11.1 Swiss Pharm Company Information

13.11.2 Swiss Pharm Mebeverine Product Offered

13.11.3 Swiss Pharm Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Swiss Pharm Main Business Overview

13.11.5 Swiss Pharm Latest Developments

13.12 Dr. Reddy's

13.12.1 Dr. Reddy's Company Information

13.12.2 Dr. Reddy's Mebeverine Product Offered

13.12.3 Dr. Reddy's Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Dr. Reddy's Main Business Overview

13.12.5 Dr. Reddy's Latest Developments

13.13 Aurovitas Pharma

13.13.1 Aurovitas Pharma Company Information

13.13.2 Aurovitas Pharma Mebeverine Product Offered

13.13.3 Aurovitas Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Aurovitas Pharma Main Business Overview

13.13.5 Aurovitas Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Mebeverine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Mebeverine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Capsule

Table 4. Major Players of Tablet

Table 5. Global Mebeverine Sales by Type (2017-2022) & (K Units)

Table 6. Global Mebeverine Sales Market Share by Type (2017-2022)

Table 7. Global Mebeverine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Mebeverine Revenue Market Share by Type (2017-2022)

Table 9. Global Mebeverine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Mebeverine Sales by Application (2017-2022) & (K Units)

Table 11. Global Mebeverine Sales Market Share by Application (2017-2022)

Table 12. Global Mebeverine Revenue by Application (2017-2022)

Table 13. Global Mebeverine Revenue Market Share by Application (2017-2022)

Table 14. Global Mebeverine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Mebeverine Sales by Company (2020-2022) & (K Units)

Table 16. Global Mebeverine Sales Market Share by Company (2020-2022)

Table 17. Global Mebeverine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Mebeverine Revenue Market Share by Company (2020-2022)

Table 19. Global Mebeverine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Mebeverine Producing Area Distribution and Sales Area

Table 21. Players Mebeverine Products Offered

Table 22. Mebeverine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Mebeverine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Mebeverine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Mebeverine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Mebeverine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Mebeverine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Mebeverine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Mebeverine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Mebeverine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Mebeverine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Mebeverine Sales Market Share by Country (2017-2022)

Table 35. Americas Mebeverine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Mebeverine Revenue Market Share by Country (2017-2022)

Table 37. Americas Mebeverine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Mebeverine Sales Market Share by Type (2017-2022)

Table 39. Americas Mebeverine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Mebeverine Sales Market Share by Application (2017-2022)

Table 41. APAC Mebeverine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Mebeverine Sales Market Share by Region (2017-2022)

Table 43. APAC Mebeverine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Mebeverine Revenue Market Share by Region (2017-2022)

Table 45. APAC Mebeverine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Mebeverine Sales Market Share by Type (2017-2022)

Table 47. APAC Mebeverine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Mebeverine Sales Market Share by Application (2017-2022)

Table 49. Europe Mebeverine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Mebeverine Sales Market Share by Country (2017-2022)

Table 51. Europe Mebeverine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Mebeverine Revenue Market Share by Country (2017-2022)

Table 53. Europe Mebeverine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Mebeverine Sales Market Share by Type (2017-2022)

Table 55. Europe Mebeverine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Mebeverine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Mebeverine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Mebeverine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Mebeverine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Mebeverine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Mebeverine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Mebeverine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Mebeverine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Mebeverine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Mebeverine

Table 66. Key Market Challenges & Risks of Mebeverine

Table 67. Key Industry Trends of Mebeverine

Table 68. Mebeverine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Mebeverine Distributors List

Table 71. Mebeverine Customer List

Table 72. Global Mebeverine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Mebeverine Sales Market Forecast by Region

Table 74. Global Mebeverine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Mebeverine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Mebeverine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Mebeverine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Mebeverine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Mebeverine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Mebeverine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Mebeverine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Mebeverine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Mebeverine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Mebeverine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Mebeverine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Mebeverine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Mebeverine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Mebeverine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Mebeverine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Mebeverine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Mebeverine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Abbott Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 93. Abbott Mebeverine Product Offered

Table 94. Abbott Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Abbott Main Business

Table 96. Abbott Latest Developments

Table 97. Mylan Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 98. Mylan Mebeverine Product Offered

Table 99. Mylan Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Mylan Main Business

Table 101. Mylan Latest Developments

Table 102. Greville Investing Limited Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 103. Greville Investing Limited Mebeverine Product Offered

Table 104. Greville Investing Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Greville Investing Limited Main Business

Table 106. Greville Investing Limited Latest Developments

Table 107. Expanscience Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 108. Expanscience Mebeverine Product Offered

Table 109. Expanscience Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Expanscience Main Business

Table 111. Expanscience Latest Developments

Table 112. Berlin Pharmaceutical Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 113. Berlin Pharmaceutical Mebeverine Product Offered

Table 114. Berlin Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Berlin Pharmaceutical Main Business

Table 116. Berlin Pharmaceutical Latest Developments

Table 117. Eipico Pharmaceutical Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 118. Eipico Pharmaceutical Mebeverine Product Offered

Table 119. Eipico Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Eipico Pharmaceutical Main Business

Table 121. Eipico Pharmaceutical Latest Developments

Table 122. Sopharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 123. Sopharma Mebeverine Product Offered

Table 124. Sopharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Sopharma Main Business

Table 126. Sopharma Latest Developments

Table 127. USV Private Limited Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 128. USV Private Limited Mebeverine Product Offered

Table 129. USV Private Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. USV Private Limited Main Business

Table 131. USV Private Limited Latest Developments

Table 132. Puren Pharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 133. Puren Pharma Mebeverine Product Offered

Table 134. Puren Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Puren Pharma Main Business

Table 136. Puren Pharma Latest Developments

Table 137. Pharco Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 138. Pharco Mebeverine Product Offered

Table 139. Pharco Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Pharco Main Business

Table 141. Pharco Latest Developments

Table 142. Swiss Pharm Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 143. Swiss Pharm Mebeverine Product Offered

Table 144. Swiss Pharm Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Swiss Pharm Main Business

Table 146. Swiss Pharm Latest Developments

Table 147. Dr. Reddy's Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 148. Dr. Reddy's Mebeverine Product Offered

Table 149. Dr. Reddy's Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Dr. Reddy's Main Business

Table 151. Dr. Reddy's Latest Developments

Table 152. Aurovitas Pharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors

Table 153. Aurovitas Pharma Mebeverine Product Offered

Table 154. Aurovitas Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Aurovitas Pharma Main Business

Table 156. Aurovitas Pharma Latest Developments

List of Figures

Figure 1. Picture of Mebeverine

Figure 2. Mebeverine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Mebeverine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Mebeverine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Mebeverine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Capsule

Figure 10. Product Picture of Tablet

Figure 11. Global Mebeverine Sales Market Share by Type in 2021

Figure 12. Global Mebeverine Revenue Market Share by Type (2017-2022)

Figure 13. Mebeverine Consumed in Hospital

Figure 14. Global Mebeverine Market: Hospital (2017-2022) & (K Units)

Figure 15. Mebeverine Consumed in Drug Store

Figure 16. Global Mebeverine Market: Drug Store (2017-2022) & (K Units)

Figure 17. Mebeverine Consumed in On-line

Figure 18. Global Mebeverine Market: On-line (2017-2022) & (K Units)

Figure 19. Global Mebeverine Sales Market Share by Application (2017-2022)

Figure 20. Global Mebeverine Revenue Market Share by Application in 2021

Figure 21. Mebeverine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Mebeverine Revenue Market Share by Company in 2021

Figure 23. Global Mebeverine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Mebeverine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Mebeverine Sales Market Share by Region (2017-2022)

Figure 26. Global Mebeverine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Mebeverine Sales 2017-2022 (K Units)

Figure 28. Americas Mebeverine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Mebeverine Sales 2017-2022 (K Units)

Figure 30. APAC Mebeverine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Mebeverine Sales 2017-2022 (K Units)

Figure 32. Europe Mebeverine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Mebeverine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Mebeverine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Mebeverine Sales Market Share by Country in 2021

Figure 36. Americas Mebeverine Revenue Market Share by Country in 2021

Figure 37. United States Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Mebeverine Sales Market Share by Region in 2021

Figure 42. APAC Mebeverine Revenue Market Share by Regions in 2021

Figure 43. China Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Mebeverine Sales Market Share by Country in 2021

Figure 50. Europe Mebeverine Revenue Market Share by Country in 2021

Figure 51. Germany Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Mebeverine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Mebeverine Revenue Market Share by Country in 2021

Figure 58. Egypt Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Mebeverine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Mebeverine in 2021

Figure 64. Manufacturing Process Analysis of Mebeverine

Figure 65. Industry Chain Structure of Mebeverine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390